Targets › SCNA1
1 program from 1 company in 1 trial: 1 Phase 4; Other; next expected readout Dec 2027.
Open in Phaseline: the race on SCNA1, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Northwestern University | Topical EMLA cream Eutectic mixture of local anesthetics (lidocaine and prilocaine) - blocks sodium channels | SCNA1, SCNB1 | Phase 4 | Hair Removal | Dec 2027 |
Hair Removal (1)
small molecule (1)
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.